These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31519060)

  • 1. Development and validation of a liquid chromatography tandem mass spectrometry quantification method for 14 cytotoxic drugs in environmental samples.
    Acramel A; Chouquet T; Plé A; Sauvageon H; Mourah S; Jouenne F; Goldwirt L
    Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8594. PubMed ID: 31519060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fully validated simple new method for environmental monitoring by surface sampling for cytotoxics.
    Rossignol E; Amiand MB; Sorrieul J; Bard JM; Bobin-Dubigeon C
    J Pharmacol Toxicol Methods; 2020; 101():106652. PubMed ID: 31734280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.
    Nussbaumer S; Geiser L; Sadeghipour F; Hochstrasser D; Bonnabry P; Veuthey JL; Fleury-Souverain S
    Anal Bioanal Chem; 2012 Mar; 402(8):2499-509. PubMed ID: 21701850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
    Fleury-Souverain S; Maurin J; Guillarme D; Rudaz S; Bonnabry P
    J Pharm Biomed Anal; 2022 Nov; 221():115034. PubMed ID: 36095884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity assessment of environmental contaminations in a hospital centralized reconstitution unit.
    Chouquet T; Acramel A; Sauvageon H; Plé A; Jourdan N; Madelaine I; Faure P; Mourah S; Goldwirt L
    Ecotoxicol Environ Saf; 2018 Dec; 165():174-181. PubMed ID: 30195999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS-MS Determination of Cytostatic Drugs on Surfaces and in Urine to Assess Occupational Exposure.
    Lema-Atán JÁ; Lendoiro E; Paniagua-González L; Cruz A; López-Rivadulla M; de-Castro-Ríos A
    J Anal Toxicol; 2023 Jan; 46(9):e248-e255. PubMed ID: 36164930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy.
    Guichard N; Boccard J; Rudaz S; Bonnabry P; Fleury Souverain S
    Eur J Hosp Pharm; 2021 Mar; 28(2):94-99. PubMed ID: 33608437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.
    Bobin-Dubigeon C; Amiand M; Percheron C; Audeval C; Rochard S; Leynia P; Bard JM
    J Anal Toxicol; 2013 Sep; 37(7):433-9. PubMed ID: 23828102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and uncertainty estimation for trace amounts determination of 25 drugs used in hospital chemotherapy compounding units.
    Guichard N; Rudaz S; Bonnabry P; Fleury-Souverain S
    J Pharm Biomed Anal; 2019 Aug; 172():139-148. PubMed ID: 31035095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS method.
    Nussbaumer S; Fleury-Souverain S; Antinori P; Sadeghipour F; Hochstrasser DF; Bonnabry P; Veuthey JL; Geiser L
    Anal Bioanal Chem; 2010 Dec; 398(7-8):3033-42. PubMed ID: 20927508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers.
    Shu P; Zhao T; Wen B; Mendelsohn-Victor K; Sun D; Friese CR; Pai MP
    J Oncol Pharm Pract; 2020 Jun; 26(4):794-802. PubMed ID: 31483750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic drugs determination by HPLC-HRMS(n) to monitor occupational exposure.
    Dal Bello F; Santoro V; Scarpino V; Martano C; Aigotti R; Chiappa A; Davoli E; Medana C
    Drug Test Anal; 2016 Jul; 8(7):730-7. PubMed ID: 26041114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement.
    Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C
    Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.
    Pretty JR; Connor TH; Spasojevic I; Kurtz KS; McLaurin JL; B'Hymer C; Debord DG
    J Oncol Pharm Pract; 2012 Mar; 18(1):23-36. PubMed ID: 21183556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicomponent high-performance liquid chromatography/tandem mass spectrometry analysis of ten chemotherapeutic drugs in wipe samples.
    Maeda S; Miwa Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():43-8. PubMed ID: 23419953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.
    Colombo M; Jeronimo M; Astrakianakis G; Apte C; Hon CY
    Ann Work Expo Health; 2017 Oct; 61(8):1003-1014. PubMed ID: 29028255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
    Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers.
    Pinet E; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2024 Jan; 30(1):19-29. PubMed ID: 37021440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.